CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: mebendazole
Accession: CHEBI:6704
browse the term
Definition: A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Synonyms: exact_synonym: methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
related_synonym: (5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester; Formula=C16H13N3O3; InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21); InChIKey=OPXLLQIJSORQAM-UHFFFAOYSA-N; MBDZ; SMILES=COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c1ccccc1; Vermox
xref: CAS:31431-39-7; DrugBank:DB00643; Drug_Central:1641; KEGG:D00368; LINCS:LSM-3749
xref_mesh: MESH:D008463
xref: PMID:6126101; Reaxys:759809; Wikipedia:Mebendazole
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression
ISO
Mebendazole results in decreased expression of ABCB1 mRNA; Mebendazole results in decreased expression of ABCB1 protein
CTD
PMID:28606429
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
decreases expression
ISO
Mebendazole results in decreased expression of ABCC1 mRNA
CTD
PMID:28606429
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Ager
advanced glycosylation end product-specific receptor
increases expression
ISO
Mebendazole results in increased expression of AGER mRNA
CTD
PMID:24747151
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Arhgef2
Rho/Rac guanine nucleotide exchange factor 2
decreases expression
ISO
Mebendazole results in decreased expression of ARHGEF2 protein
CTD
PMID:30075109
NCBI chr 2:174,061,126...174,118,355
Ensembl chr 2:174,062,976...174,118,355
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
[Mebendazole results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]
CTD
PMID:18667591
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
affects response to substance increases phosphorylation multiple interactions
ISO
BCL2 protein affects the susceptibility to Mebendazole Mebendazole results in increased phosphorylation of BCL2 protein [Mebendazole results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]
CTD
PMID:18667591
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bmp6
bone morphogenetic protein 6
increases expression
ISO
Mebendazole results in increased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Casp3
caspase 3
increases activity
ISO
Mebendazole results in increased activity of CASP3 protein
CTD
PMID:37473966
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
increases activity
ISO
Mebendazole results in increased activity of CASP7 protein
CTD
PMID:37473966
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Ccl2
C-C motif chemokine ligand 2
increases expression
ISO
Mebendazole results in increased expression of CCL2 protein
CTD
PMID:20116850
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Cdh1
cadherin 1
multiple interactions
ISO
Mebendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]
CTD
PMID:30075109
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Cdh2
cadherin 2
multiple interactions
ISO
Mebendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH2 protein]
CTD
PMID:30075109
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO EXP
Mebendazole results in increased expression of CYP1A1 mRNA; Mebendazole results in increased expression of CYP1A1 protein
CTD
PMID:9860486 PMID:12841937
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases expression
ISO EXP
Mebendazole results in increased expression of CYP1A2 protein
CTD
PMID:12841937
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Ereg
epiregulin
increases expression
ISO
Mebendazole results in increased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Mebendazole results in increased expression of FOS mRNA
CTD
PMID:12730611
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
decreases expression affects binding
ISO
Mebendazole results in decreased expression of GAPDH mRNA Mebendazole binds to GAPDH protein
CTD
PMID:37473966
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gstp1
glutathione S-transferase pi 1
multiple interactions
ISO
Mebendazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]
CTD
PMID:23769903
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Hes1
hes family bHLH transcription factor 1
decreases expression
ISO
Mebendazole results in decreased expression of HES1 protein
CTD
PMID:32277947
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
G
Hk1
hexokinase 1
affects binding decreases expression
ISO
Mebendazole binds to HK1 protein Mebendazole results in decreased expression of HK1 mRNA
CTD
PMID:37473966
NCBI chr20:30,230,488...30,332,099
Ensembl chr20:30,230,486...30,332,131
G
Il1a
interleukin 1 alpha
increases expression
ISO
Mebendazole results in increased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
increases expression
ISO
Mebendazole results in increased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il24
interleukin 24
increases expression
ISO
Mebendazole results in increased expression of IL24 mRNA
CTD
PMID:32816093
NCBI chr13:42,353,089...42,358,487
Ensembl chr13:42,353,090...42,358,487
G
Il6r
interleukin 6 receptor
increases expression
ISO
Mebendazole results in increased expression of IL6R protein modified form
CTD
PMID:20116850
NCBI chr 2:175,289,157...175,347,719
Ensembl chr 2:175,298,686...175,347,536
G
Ldha
lactate dehydrogenase A
decreases activity decreases expression affects binding
ISO
Mebendazole results in decreased activity of LDHA protein Mebendazole results in decreased expression of LDHA mRNA Mebendazole binds to LDHA protein
CTD
PMID:37473966
NCBI chr 1:97,371,823...97,381,247
Ensembl chr 1:97,366,021...97,433,472
G
Mapk1
mitogen activated protein kinase 1
increases phosphorylation
ISO
Mebendazole results in increased phosphorylation of MAPK1 protein
CTD
PMID:20848085
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases phosphorylation
ISO
Mebendazole results in increased phosphorylation of MAPK3 protein
CTD
PMID:20848085
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
increases phosphorylation
ISO
Mebendazole results in increased phosphorylation of MAPK8 protein
CTD
PMID:20848085
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation
ISO
Mebendazole results in increased phosphorylation of MAPK9 protein
CTD
PMID:20848085
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
Mebendazole results in decreased expression of MAPT protein
CTD
PMID:16930453
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Mebendazole results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
Mebendazole results in decreased expression of MYC mRNA; Mebendazole results in decreased expression of MYC protein
CTD
PMID:31207347 PMID:32277947
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Nlrp3
NLR family, pyrin domain containing 3
increases expression
ISO
Mebendazole results in increased expression of NLRP3 mRNA
CTD
PMID:24747151
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
G
Notch1
notch receptor 1
decreases expression
ISO
Mebendazole results in decreased expression of NOTCH1 protein
CTD
PMID:32277947
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
multiple interactions
ISO
Mebendazole inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein]
CTD
PMID:25257666
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Mebendazole results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Mebendazole results in increased expression of PTGS2 mRNA
CTD
PMID:32816093
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
Mebendazole results in decreased expression of PTK2 protein
CTD
PMID:30075109
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
G
Rac1
Rac family small GTPase 1
decreases expression
ISO
Mebendazole results in decreased expression of RAC1 protein
CTD
PMID:30075109
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
G
Rhoa
ras homolog family member A
decreases expression
ISO
Mebendazole results in decreased expression of RHOA protein
CTD
PMID:30075109
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
G
S100a8
S100 calcium binding protein A8
increases expression
ISO
Mebendazole results in increased expression of S100A8 mRNA
CTD
PMID:24747151
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
increases expression
ISO
Mebendazole results in increased expression of S100A9 mRNA
CTD
PMID:24747151
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Slc2a1
solute carrier family 2 member 1
affects binding decreases expression
ISO
Mebendazole binds to SLC2A1 protein Mebendazole results in decreased expression of SLC2A1 mRNA
CTD
PMID:37473966
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Slc47a1
solute carrier family 47 member 1
decreases expression
ISO
Mebendazole results in decreased expression of SLC47A1 mRNA
CTD
PMID:28606429
NCBI chr10:46,034,115...46,088,617
Ensembl chr10:46,034,122...46,087,637
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
Mebendazole results in increased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
Mebendazole results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
Mebendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH1 protein]; Mebendazole inhibits the reaction [TGFB1 protein results in increased expression of CDH2 protein]
CTD
PMID:30075109
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Mebendazole binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Tnf
tumor necrosis factor
multiple interactions increases secretion increases expression
ISO
U 0126 inhibits the reaction [Mebendazole results in increased secretion of TNF protein] Mebendazole results in increased expression of TNF mRNA
CTD
PMID:20848085 PMID:24747151
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
Mebendazole results in increased expression of VEGFA protein
CTD
PMID:20116850
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all